Loading…
Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study
Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for...
Saved in:
Published in: | Nature communications 2023-03, Vol.14 (1), p.1746-1746, Article 1746 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3 |
---|---|
cites | cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3 |
container_end_page | 1746 |
container_issue | 1 |
container_start_page | 1746 |
container_title | Nature communications |
container_volume | 14 |
creator | Wang, Qianli Wang, Wei Winter, Amy K. Zhan, Zhifei Ajelli, Marco Trentini, Filippo Wang, Lili Li, Fangcai Yang, Juan Xiang, Xingyu Liao, Qiaohong Zhou, Jiaxin Guo, Jinxin Yan, Xuemei Liu, Nuolan Metcalf, C. Jessica E. Grenfell, Bryan T. Yu, Hongjie |
description | Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities.
The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China. |
doi_str_mv | 10.1038/s41467-023-37407-x |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3</doaj_id><sourcerecordid>2792902315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEolXpC7BAkdiwIOC74xVCIy6VRmIDa8vxJeORYw92Ujpvj6cppWWBNz4-5z-fb3_TvITgHQS4f18IJIx3AOEOcwJ4d_OkOUeAwA5yhJ8-iM-ay1L2oA4sYE_I8-YMMyGA6Nl5s9umOHazzVM7WVWCLa2Ksx-SObaHnJw_ZVwKIf3ycWyNd85mG-f2Wmnto22L3lmznFQ-tpudj-ptq9pQqX5eTF2GttTg-KJ55lQo9vJuvmh-fP70ffO12377crX5uO00JXDu-MCZg5iyXnGjoRaCsB6DATHsKNCMMKqw49pwhAA2jpCBAqV7Rikwwjh80VytXJPUXh6yn1Q-yqS8vE2kPEqVZ6-DlcBWTM8VhdoRSwc1ODWY3nCDHOIWV9aHlXVYhskaXe-dVXgEfVyJfifHdC0hAJQgyCvhzR0hp5-LLbOcfNE2BBVtWopEXCBR_xDSKn39j3Sfllzfb1VBQRlDVYVWlc6plGzd_WkgkCdjyNUYskLlrTHkTW169fAe9y1_bFAFeBWUWoqjzX_3_g_2N1pmxfQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2792195662</pqid></control><display><type>article</type><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><source>Publicly Available Content Database</source><source>Nature</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</creator><creatorcontrib>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</creatorcontrib><description>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities.
The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</description><identifier>ISSN: 2041-1723</identifier><identifier>EISSN: 2041-1723</identifier><identifier>DOI: 10.1038/s41467-023-37407-x</identifier><identifier>PMID: 36990986</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>101/1 ; 631/326/590 ; 631/326/596/1631 ; 692/699/255/2514 ; 692/700/478/174 ; Adolescent ; Antibodies ; Antibodies, Viral ; Child ; Children ; China - epidemiology ; Health risks ; Humanities and Social Sciences ; Humans ; Immune response ; Immune system ; Immunity ; Immunization ; Infant ; Kinetics ; Longitudinal Studies ; Measles ; Measles - epidemiology ; Measles - prevention & control ; Measles Vaccine ; multidisciplinary ; Prospective Studies ; Schedules ; Science ; Science (multidisciplinary) ; Vaccination ; Vaccines</subject><ispartof>Nature communications, 2023-03, Vol.14 (1), p.1746-1746, Article 1746</ispartof><rights>The Author(s) 2023. corrected publication 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</citedby><cites>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</cites><orcidid>0000-0003-1753-4749 ; 0000-0001-5028-2227 ; 0000-0002-6335-5648 ; 0000-0003-3166-7521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2792195662/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2792195662?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,25755,27926,27927,37014,37015,44592,53793,53795,75128</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36990986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Qianli</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Winter, Amy K.</creatorcontrib><creatorcontrib>Zhan, Zhifei</creatorcontrib><creatorcontrib>Ajelli, Marco</creatorcontrib><creatorcontrib>Trentini, Filippo</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Li, Fangcai</creatorcontrib><creatorcontrib>Yang, Juan</creatorcontrib><creatorcontrib>Xiang, Xingyu</creatorcontrib><creatorcontrib>Liao, Qiaohong</creatorcontrib><creatorcontrib>Zhou, Jiaxin</creatorcontrib><creatorcontrib>Guo, Jinxin</creatorcontrib><creatorcontrib>Yan, Xuemei</creatorcontrib><creatorcontrib>Liu, Nuolan</creatorcontrib><creatorcontrib>Metcalf, C. Jessica E.</creatorcontrib><creatorcontrib>Grenfell, Bryan T.</creatorcontrib><creatorcontrib>Yu, Hongjie</creatorcontrib><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><title>Nature communications</title><addtitle>Nat Commun</addtitle><addtitle>Nat Commun</addtitle><description>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities.
The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</description><subject>101/1</subject><subject>631/326/590</subject><subject>631/326/596/1631</subject><subject>692/699/255/2514</subject><subject>692/700/478/174</subject><subject>Adolescent</subject><subject>Antibodies</subject><subject>Antibodies, Viral</subject><subject>Child</subject><subject>Children</subject><subject>China - epidemiology</subject><subject>Health risks</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunization</subject><subject>Infant</subject><subject>Kinetics</subject><subject>Longitudinal Studies</subject><subject>Measles</subject><subject>Measles - epidemiology</subject><subject>Measles - prevention & control</subject><subject>Measles Vaccine</subject><subject>multidisciplinary</subject><subject>Prospective Studies</subject><subject>Schedules</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>2041-1723</issn><issn>2041-1723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEolXpC7BAkdiwIOC74xVCIy6VRmIDa8vxJeORYw92Ujpvj6cppWWBNz4-5z-fb3_TvITgHQS4f18IJIx3AOEOcwJ4d_OkOUeAwA5yhJ8-iM-ay1L2oA4sYE_I8-YMMyGA6Nl5s9umOHazzVM7WVWCLa2Ksx-SObaHnJw_ZVwKIf3ycWyNd85mG-f2Wmnto22L3lmznFQ-tpudj-ptq9pQqX5eTF2GttTg-KJ55lQo9vJuvmh-fP70ffO12377crX5uO00JXDu-MCZg5iyXnGjoRaCsB6DATHsKNCMMKqw49pwhAA2jpCBAqV7Rikwwjh80VytXJPUXh6yn1Q-yqS8vE2kPEqVZ6-DlcBWTM8VhdoRSwc1ODWY3nCDHOIWV9aHlXVYhskaXe-dVXgEfVyJfifHdC0hAJQgyCvhzR0hp5-LLbOcfNE2BBVtWopEXCBR_xDSKn39j3Sfllzfb1VBQRlDVYVWlc6plGzd_WkgkCdjyNUYskLlrTHkTW169fAe9y1_bFAFeBWUWoqjzX_3_g_2N1pmxfQ</recordid><startdate>20230329</startdate><enddate>20230329</enddate><creator>Wang, Qianli</creator><creator>Wang, Wei</creator><creator>Winter, Amy K.</creator><creator>Zhan, Zhifei</creator><creator>Ajelli, Marco</creator><creator>Trentini, Filippo</creator><creator>Wang, Lili</creator><creator>Li, Fangcai</creator><creator>Yang, Juan</creator><creator>Xiang, Xingyu</creator><creator>Liao, Qiaohong</creator><creator>Zhou, Jiaxin</creator><creator>Guo, Jinxin</creator><creator>Yan, Xuemei</creator><creator>Liu, Nuolan</creator><creator>Metcalf, C. Jessica E.</creator><creator>Grenfell, Bryan T.</creator><creator>Yu, Hongjie</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1753-4749</orcidid><orcidid>https://orcid.org/0000-0001-5028-2227</orcidid><orcidid>https://orcid.org/0000-0002-6335-5648</orcidid><orcidid>https://orcid.org/0000-0003-3166-7521</orcidid></search><sort><creationdate>20230329</creationdate><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><author>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>101/1</topic><topic>631/326/590</topic><topic>631/326/596/1631</topic><topic>692/699/255/2514</topic><topic>692/700/478/174</topic><topic>Adolescent</topic><topic>Antibodies</topic><topic>Antibodies, Viral</topic><topic>Child</topic><topic>Children</topic><topic>China - epidemiology</topic><topic>Health risks</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunization</topic><topic>Infant</topic><topic>Kinetics</topic><topic>Longitudinal Studies</topic><topic>Measles</topic><topic>Measles - epidemiology</topic><topic>Measles - prevention & control</topic><topic>Measles Vaccine</topic><topic>multidisciplinary</topic><topic>Prospective Studies</topic><topic>Schedules</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Qianli</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Winter, Amy K.</creatorcontrib><creatorcontrib>Zhan, Zhifei</creatorcontrib><creatorcontrib>Ajelli, Marco</creatorcontrib><creatorcontrib>Trentini, Filippo</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Li, Fangcai</creatorcontrib><creatorcontrib>Yang, Juan</creatorcontrib><creatorcontrib>Xiang, Xingyu</creatorcontrib><creatorcontrib>Liao, Qiaohong</creatorcontrib><creatorcontrib>Zhou, Jiaxin</creatorcontrib><creatorcontrib>Guo, Jinxin</creatorcontrib><creatorcontrib>Yan, Xuemei</creatorcontrib><creatorcontrib>Liu, Nuolan</creatorcontrib><creatorcontrib>Metcalf, C. Jessica E.</creatorcontrib><creatorcontrib>Grenfell, Bryan T.</creatorcontrib><creatorcontrib>Yu, Hongjie</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Nature communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Qianli</au><au>Wang, Wei</au><au>Winter, Amy K.</au><au>Zhan, Zhifei</au><au>Ajelli, Marco</au><au>Trentini, Filippo</au><au>Wang, Lili</au><au>Li, Fangcai</au><au>Yang, Juan</au><au>Xiang, Xingyu</au><au>Liao, Qiaohong</au><au>Zhou, Jiaxin</au><au>Guo, Jinxin</au><au>Yan, Xuemei</au><au>Liu, Nuolan</au><au>Metcalf, C. Jessica E.</au><au>Grenfell, Bryan T.</au><au>Yu, Hongjie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</atitle><jtitle>Nature communications</jtitle><stitle>Nat Commun</stitle><addtitle>Nat Commun</addtitle><date>2023-03-29</date><risdate>2023</risdate><volume>14</volume><issue>1</issue><spage>1746</spage><epage>1746</epage><pages>1746-1746</pages><artnum>1746</artnum><issn>2041-1723</issn><eissn>2041-1723</eissn><abstract>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities.
The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36990986</pmid><doi>10.1038/s41467-023-37407-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1753-4749</orcidid><orcidid>https://orcid.org/0000-0001-5028-2227</orcidid><orcidid>https://orcid.org/0000-0002-6335-5648</orcidid><orcidid>https://orcid.org/0000-0003-3166-7521</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2041-1723 |
ispartof | Nature communications, 2023-03, Vol.14 (1), p.1746-1746, Article 1746 |
issn | 2041-1723 2041-1723 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3 |
source | Publicly Available Content Database; Nature; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 101/1 631/326/590 631/326/596/1631 692/699/255/2514 692/700/478/174 Adolescent Antibodies Antibodies, Viral Child Children China - epidemiology Health risks Humanities and Social Sciences Humans Immune response Immune system Immunity Immunization Infant Kinetics Longitudinal Studies Measles Measles - epidemiology Measles - prevention & control Measles Vaccine multidisciplinary Prospective Studies Schedules Science Science (multidisciplinary) Vaccination Vaccines |
title | Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T10%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20measles%20antibody%20profiles%20following%20different%20vaccine%20schedules%20in%20China,%20a%20longitudinal%20study&rft.jtitle=Nature%20communications&rft.au=Wang,%20Qianli&rft.date=2023-03-29&rft.volume=14&rft.issue=1&rft.spage=1746&rft.epage=1746&rft.pages=1746-1746&rft.artnum=1746&rft.issn=2041-1723&rft.eissn=2041-1723&rft_id=info:doi/10.1038/s41467-023-37407-x&rft_dat=%3Cproquest_doaj_%3E2792902315%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2792195662&rft_id=info:pmid/36990986&rfr_iscdi=true |